Northwest Biotherapeutics Inc
NWBO· OTC
NWBONorthwest Biotherapeutics Inc
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001144204-12-045640
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $330.00K | $0.00 | $0.00 |
| Net Income | -$10.15M | -$12.33M | -$8.73M |
| EPS Diluted | -$0.06 | -$0.15 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end
